Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Erytech Pharma SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Erytech Pharma SA

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

27 Sep 2016 Wright Reports 64 $75.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech) is a biopharmaceutical company that ...

12 Sep 2016 GlobalData 43 $300.00

Termination of coverage - Erytech

Edison Investment Research is terminating coverage on Erytech Pharma (EYRP). Please note you should no longer rely on any pre...

12 Aug 2016 Edison Investment Research 1 $10.00

ERYTECH PHARMA - DENSE NEWSFLOW DURING NEXT 12 MONTHS

Erytech’s lead indication, acute lymphocytic leukaemia (ALL), is being explored in a comprehensive programme for its Graspa t...

29 Jul 2016 Edison Investment Research 8 $10.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech) is a biopharmaceutical company that ...

17 Jun 2016 GlobalData 44 $300.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech) is a biopharmaceutical company that ...

17 Mar 2016 GlobalData 53 $300.00

ERYTECH PHARMA: ADR UPDATE - PRIVATE PLACEMENT TO PURSUE GRASPA STRATEGY

The recent €25.4m ($27.7m) private placement provides Erytech with a healthy cash balance, which should allow effective execu...

17 Dec 2015 Edison Investment Research 5 $10.00

ERYTECH PHARMA - PRIVATE PLACEMENT TO PURSUE GRASPA STRATEGY

The recent €25.4m private placement provides Erytech with a healthy cash balance, which should allow effective execution on t...

17 Dec 2015 Edison Investment Research 5 $10.00

Erytech Pharma SA (ERYP) - Financial Analysis Review

Erytech Pharma SA (ERYP) - Financial Analysis Review Summary Erytech Pharma SA (Erytech Pharma) is a bio-pharmaceutical compa...

02 Dec 2015 GlobalData 48 $300.00